A diverse group of businesses and products drove growth during the quarter
Earlier today, Medtronic announced financial results for the third quarter of fiscal year 2023.
Here are three things to know:
A healthy rebound
Medtronic outperformed Wall Street analysts’ expectations during the third quarter and is urgently forging a path toward durable growth.
A diverse group of business and products drove growth during the quarter, including the tiny Micra™ leadless pacemaker, the Aible™ spinal surgical suite of technologies, and the GI Genius™ module, which uses AI to detect polyps during colonoscopies.
A transformation is underway
An aggressive transformation is underway at Medtronic. The company is streamlining, enhancing its culture, better managing its portfolio, and upgrading its manufacturing operations and supply chain capabilities.